scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1083400169 |
P356 | DOI | 10.1245/S10434-017-5768-8 |
P932 | PMC publication ID | 5339323 |
P698 | PubMed publication ID | 28144760 |
P50 | author | Steven Rosenberg | Q2347448 |
P2093 | author name string | Tristen S Park | |
Donald E White | |||
Giao Q Phan | |||
James C Yang | |||
Kathleen E Morton | |||
Marybeth S Hughes | |||
Richard M Sherry | |||
Kasia Trebska-McGowan | |||
Udai Kammula | |||
P2860 | cites work | Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma | Q73254695 |
NCCN melanoma practice guidelines. National Comprehensive Cancer Network | Q77070881 | ||
Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy | Q78863642 | ||
Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging | Q83055877 | ||
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy | Q24596055 | ||
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma | Q27860650 | ||
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 | ||
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma | Q29615443 | ||
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma | Q34086791 | ||
High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update | Q34507305 | ||
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines | Q34657707 | ||
Different adjuvanticity of incomplete freund's adjuvant derived from beef or vegetable components in melanoma patients immunized with a peptide vaccine. | Q35638553 | ||
CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma | Q35871798 | ||
Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma | Q36027584 | ||
Primary staging and follow-up in melanoma patients--monocenter evaluation of methods, costs and patient survival | Q36645881 | ||
Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines | Q36875380 | ||
Surveillance after surgical treatment of melanoma: Futility of routine chest radiography | Q37783750 | ||
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial | Q38404655 | ||
Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines | Q40234159 | ||
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma | Q45287769 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P921 | main subject | tomography | Q841267 |
P304 | page(s) | 947-951 | |
P577 | publication date | 2017-01-31 | |
P1433 | published in | Annals of Surgical Oncology | Q2853069 |
P1476 | title | Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients | |
P478 | volume | 24 |
Q92106711 | Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy |
Q41557948 | Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test |
Q93002898 | Surveillance imaging for metastasis in high-risk melanoma: importance in individualized patient care and survivorship |
Search more.